The K+–Cl− cotransporter 2 (KCC2) plays an important role in inhibitory neurotransmission, and its impairment is associated with neurological and psychiatric disorders, including epilepsy, schizophrenia, and autism. This evidence concerns the gene SLC12A5 and epilepsy.